Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix President Siegel Steps Down; No Replacement Named

NEW YORK, April 19 (GenomeWeb News) - Susan Siegel has resigned as president of Affymetrix, the company said today.


The company also said that "effective immediately," Thane Kreiner, vice president of corporate affairs, has been named senior vice president of marketing and sales.


Affymetrix said Siegel will be "transitioning from her current role" and will represent the company as president emeritus. Affy said she will stay on as an advisor and continue to report to Chairman and CEO Stephen Fodor.


It was not immediately clear why Siegel stepped down, whether the resignation takes immediate effect, or whether Kreiner's role will overlap her duties. Also not clear is whether Affy has begun looking for a replacement.


An Affymetrix spokesman said the company will "address these questions when we're ready, at the appropriate time."


Siegel joined Affymetrix in 1998 as senior vice president of sales and marketing -- the same title to which Kreiner was now promoted. Affy named her president in 1999 and appointed her to the board two years later.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.